Next Article in Journal
Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis
Previous Article in Journal
Glutamatergic Signaling a Therapeutic Vulnerability in Melanoma
Previous Article in Special Issue
Intersection of Two Checkpoints: Could Inhibiting the DNA Damage Response Checkpoint Rescue Immune Checkpoint-Refractory Cancer?
 
 
Review

Article Versions Notes

Cancers 2021, 13(15), 3870; https://doi.org/10.3390/cancers13153870
Action Date Notes Link
article xml file uploaded 31 July 2021 13:18 CEST Original file -
article xml uploaded. 31 July 2021 13:19 CEST Update https://www.mdpi.com/2072-6694/13/15/3870/xml
article pdf uploaded. 31 July 2021 13:19 CEST Version of Record https://www.mdpi.com/2072-6694/13/15/3870/pdf
article html file updated 31 July 2021 13:20 CEST Original file -
article html file updated 27 July 2022 07:40 CEST Update https://www.mdpi.com/2072-6694/13/15/3870/html
Back to TopTop